Table 1.
lncRNAs | cancer/cell types | regulation status | references |
---|---|---|---|
NR2F21 | NPC | down | [13] |
FAM95C | NPC | down | [13] |
LINC01106 | NPC | down | [13] |
CH507-513H4.6 | NPC | up | [13] |
HAP9-AS1 | NPC | up | [13] |
CH507-513H4.3 | NPC | up | [13] |
RP4-794H19.1 | NPC | up | [13] |
LINC00312(NAG7) | NPC | down | [13] |
LOC553103 | NPC | down | [14] |
APAF1-AS1 | NPC | up | [15] |
AL359062 | NPC | up | [15] |
SNHG8 | EBVaGC | up | [16] |
RP5-1039 K5.19 | EBVaGC | up | [17] |
TP73-AS1 | EBVaGC | up | [17] |
MALAT1 | NPC | up | [15] |
293-EBV, AGS-EBV | up | [18] | |
NPC C666–1 | down | [19, 20] | |
diffuse large B cell lymphoma | up | ||
BC200 | 293-EBV, AGS-EBV, C666–1 | up | [18] |
LINC00672 | 293-EBV, AGS-EBV, C666–1 | up | [18] |
LINC00982 | 293-EBV, C666–1 | up | [18] |
AGS-EBV | down | [18] | |
LINC02067 |
293-EBV, AGS-EBV C666–1 |
down no change |
[18] |
LOC100128494 | 293-EBV | down | [18] |
AGS-EBV, C666–1 | up | [18] | |
LOC100505716 | 293-EBV, AGS-EBV, C666–1 | down | [18] |
IGFBP7-AS1 | 293-EBV | down | [18] |
CYTOR | LCL | up | [20] |
NORAD | LCL | down | [20] |
7SL | LCL and exosomes | up | [21] |
H19 | LCL and exosomes | up | [21] |
H19-AS | LCL and exosomes | up | [21] |
NPC Nasopharyngeal carcinoma, EBVaGC EBV associated gastric carcinoma, LCL Lymphoblastoid cell line